Aaron Welch, PhD

Aaron focuses on investment due diligence, execution, and monitoring. Prior to SymBiosis, he worked in corporate strategy and operations at Cytovia Therapeutics and was an Equity Research Associate covering SMID cap biotechnology companies at H.C. Wainwright and Guggenheim Partners. He began his career as an Assistant Professor at Florida International University. Aaron holds a PhD in cellular biology from The Johns Hopkins University and a bachelor’s degree in biochemistry from the University of Kansas.